Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Prostatic Neoplasms 9Leukemia, Myeloid, Acute 9Endometrial Neoplasms 8Breast Neoplasms 7Oropharyngeal Neoplasms 5Neoplasm Metastasis 5Lung Neoplasms 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Multiple Myeloma 4Melanoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Colorectal Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Neuroblastoma 3Mouth Neoplasms 3Lymphoma, Follicular 3Leukemia 3Esophageal Neoplasms 3Brain Neoplasms 3

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 9Ciprofloxacin 7Voriconazole 5Caspofungin 4Amoxicillin-Potassium Clavulanate Combination 4gamma-Globulins 3Vancomycin 3Fluconazole 3Filgrastim 3Daptomycin 3Antibiotic Prophylaxis 3plerixafor 2liposomal amphotericin B 2Trimethoprim 2Therapeutics 2Sulfamethoxazole 2Saline Solution 2Ribavirin 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Moxifloxacin 2Melphalan 2Levofloxacin 2Itraconazole 2Immunoglobulins, Intravenous 2Granulocyte Colony-Stimulating Factor 2Ethanol 2Cyclophosphamide 2Cefazolin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Infections × Observation × Clear all
NCT02624440 2015-12-08

SUTRICA

Aalborg University Hospital

Phase 2 Unknown
300 enrolled
Plasma cell

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡